The abstract is read at the publisher; the summary is JClub's.
BB@PCB-HA, a surface-functionalized Bifidobacterium bifidum formulation, markedly alleviates inflammation and restores epithelial barrier integrity, community structure, and metabolic function in CDI and recurrent CDI mouse models.
- Why it matters: CDI disrupts gut ecology, causing loss of colonization resistance, persistent inflammatory feedback, and incomplete microbial recovery; Bifidobacterium depletion is linked to CDI-associated dysbiosis.
- What they did: In vitro assays screened strains and identified Bifidobacterium bifidum as most protective via mucus/epithelial adhesion and competition for epithelial attachment sites; then BB@PCB-HA combined BHB with an outer hyaluronic-acid coating.
- The result: In both CDI and recurrent CDI mouse models, the sequential BB@PCB-HA strategy reduces inflammation and enables recovery of epithelial barrier integrity and gut microbiota structure and metabolic function.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.